Beat The Denominator

Palantir (PLTR) is a high-conviction "catch-up" trade, as its stellar 80%+ revenue growth in the U.S. commercial and government sectors suggests it is overdue for a rally compared to hardware peers. Despite its reputation, PLTR is considered mathematically cheap at current levels and serves as a core "N-of-1" software play for those looking beyond the hardware boom. NVIDIA (NVDA) remains a top-tier conviction buy, described as "super cheap" and undervalued with a valuation metric of 0.61 ahead of its next growth phase. While Micron (MU) has already seen a parabolic move, it remains surprisingly inexpensive at a 0.28 valuation metric, though investors should be mindful of its historical cyclicality. Avoid chasing the recent parabolic surge in AMD, and instead focus on the rotation into "load-bearing" AI infrastructure like PLTR and NVDA that provides essential sovereign and institutional software.

Investors seeking high-yield income should prioritize STRC, which is transitioning to a twice-monthly dividend schedule potentially starting in July. Bitcoin (BTC) is currently viewed as a "value" play at the $81,000 level, offering a favorable entry point before a projected move toward the $126,000 range. While MicroStrategy (MSTR) may sell Bitcoin at a loss for strategic tax-loss harvesting, investors should view these "bad headlines" as tactical moves rather than a loss of conviction. Management considers MSTR common stock undervalued at current Net Asset Value multiples, suggesting long-term upside as the company rebrands into an AI-focused entity via its Mosaic platform. Monitor the company's integration with Snowflake (SNOW), as this neutral software layer is designed to drive the next phase of institutional adoption.

Investors should consider Oscar Health (OSCAR) as a high-conviction growth play, given its massive 53% year-over-year revenue growth and a valuation that remains "dirt cheap" relative to its peers. The company is aggressively targeting the gig economy and employer-sponsored ICHRAs, positioning it to capture a more profitable and less regulated segment of the healthcare market. Management’s conservative Medical Loss Ratio (MLR) guidance of 83% suggests a high likelihood of future earnings beats if they maintain their current operational efficiency. OSCAR is also leveraging AI agents to structurally lower costs and improve margins, a technological edge that traditional insurers like UnitedHealth Group (UNH) may struggle to replicate quickly. With a target of $19 billion in revenue by 2026, this stock offers a significant contrarian opportunity for those looking to diversify into high-growth healthcare.

Investors should treat MicroStrategy (MSTR) as a high-volatility, high-yield savings product designed to capture Bitcoin (BTC) growth through aggressive at-the-market equity offerings. For those with a lower risk tolerance, STRC serves as a lower-volatility alternative to preserve purchasing power against fiat devaluation. Monitor the upcoming "ex-dividend" date this Friday, as it is expected to be a significant catalyst for trading volume and price volatility. Bitcoin remains the primary long-term hold with a multi-decadal horizon, acting as a mathematical hedge against a weakening US Dollar and a target of $30 million per coin. Avoid traditional fixed-income assets in favor of these "hard money" instruments to capture a natural yield that far exceeds manipulated government interest rates.

Investors should monitor HIMS for a potential short squeeze, as its high 35% short float could drive prices well above the current $29 level following positive news. With a 79% probability of an earnings beat, the stock remains a high-conviction play for those betting on the company’s transition into an AI-driven healthcare provider. Look for the successful rollout of their AI care agent to significantly improve profit margins by automating routine medical consultations and lab results. The departure of key FDA officials may reduce regulatory risks, making this an opportune time to build a position as the legal "overhang" on personalized compounding fades. Focus on the long-term shift toward customized medicine and data collection, treating current price volatility as an entry point into the future of AI-designed healthcare.

Celsius Holdings (CELH) presents a high-conviction growth opportunity as it disrupts the beverage market, currently trading at a valuation significantly cheaper than peers like Dutch Bros (BROS). Investors should capitalize on the stock being "left for dead" by the market despite its massive +126% year-over-year sales growth and dominant 20.9% market share. The strategic acquisition of Alani Nu provides a unique edge by capturing the underserved female demographic, while the core brand successfully steals morning market share from Starbucks (SBUX). Look for long-term upside driven by a massive "blue ocean" expansion into Europe and a permanent shift in Gen Z consumption habits away from coffee. Focus on CELH as a top pick in the consumer sector for its ability to maintain 50% gross margins while evolving into a global lifestyle brand.

Investors should view recent Bitcoin sales by MicroStrategy (MSTR) as a tactical tax-loss harvesting move to capture a $2 billion benefit rather than a loss of conviction. Management is aggressively targeting S&P 500 inclusion by seeking formal credit ratings and optimizing their "Bitcoin per share" metric, which could drive the market cap toward a $300 billion valuation. The recovery of the STRC credit instrument to its $100 par value is a bullish signal, providing the company with the necessary capital to continue large-scale BTC acquisitions. While Bitcoin remains the core driver, Michael Saylor’s softening stance on other networks like Solana (SOL) suggests a potential future broadening of the company’s digital asset strategy. With leadership now actively aiming to "rip the shorts," MSTR is positioned for high volatility and a potential short squeeze if the market begins valuing its holdings at standard equity multiples.

Zeta Global (ZETA) presents a high-conviction "universally cheap" AI opportunity, trading at a rare 0.14 valuation multiple despite a dominant proprietary database and strong Rule of 40 performance. Investors should look to Hims & Hers Health (HIMS) as a discounted growth play in personalized medicine, specifically for its expansion into GLP-1 weight-loss drugs and a valuation currently under 0.1 EV/GP/RG. SoFi Technologies (SOFI) is a primary recovery candidate to accumulate now, as it is positioned to surge once interest rates begin to decline. Within the blockchain sector, Solana (SOL) is the preferred network for speed and adoption, with Forward Industries (FORD) serving as a strategic proxy for traditional brokerage accounts. While many AI leaders are currently overheated, NVIDIA (NVDA) remains the only major chip play with a fair valuation relative to its growth, whereas Tesla (TSLA) offers long-term value in the emerging physical AI space.

Investors should consider MicroStrategy (MSTR) as a high-conviction play while it trades at a perceived discount, especially as the company aggressively targets a balance sheet of 1.6 million Bitcoin. For those seeking income, MicroStrategy Preferred Shares (STRC) offer a compelling 11.5% yield and are currently trading below par value, providing a strategic entry point for both retail and institutional treasuries. You can access STRC through traditional brokerages like Schwab and Fidelity or via specialized ETFs such as PFXF and PFF. While NVIDIA (NVDA) remains fairly valued, investors should exercise extreme caution and consider taking profits in overheated AI stocks like Nebius (NBIS), which has seen an unsustainable run toward $190. The current market shift toward AI momentum has created a temporary valuation gap in Bitcoin-related equities, offering a time-sensitive window to accumulate before the narrative returns to crypto fundamentals.

Investors seeking leveraged exposure to Bitcoin (BTC) should consider MicroStrategy (MSTR), which aims to double its Bitcoin-per-share holdings by 2032 through aggressive "accretive" growth. The company is transitioning into an active "Bitcoin bank," utilizing tax-loss harvesting, debt buybacks, and Bitcoin derivatives like covered calls to outperform the underlying asset. Monitor the Market Value to Net Asset Value (MNAV) ratio; a rise toward 1.75x typically signals a new round of share issuance to fund massive BTC acquisitions. For those interested in yield-generating digital assets, Marathon Digital Holdings (MARA) offers a similar strategy by selling call options to monetize its holdings. With a projected 5x price appreciation for Bitcoin by 2032, these stocks serve as high-conviction plays for capturing amplified returns relative to the spot market.

Investors should prioritize monitoring weekly 8-K filings over quarterly earnings to track MicroStrategy (MSTR), as these filings disclose the critical Bitcoin acquisitions that drive the stock's value. MSTR currently trades at a 1.27x premium to its Bitcoin holdings, making it a high-conviction vehicle for those seeking leveraged exposure to Bitcoin (BTC) with an additional "Bitcoin Yield" targeted at 20-25% annually. For more conservative investors, MicroStrategy Credit (STRC) offers a "stripped volatility" alternative that provides exposure to the ecosystem with significantly less price swing than the equity. The company’s shift toward a cloud-based software model and its "return of capital" accounting provides unique tax advantages, effectively subsidizing the core business through Bitcoin gains. Ultimately, MSTR should be viewed as a Bitcoin development bank where the stock price will move in lockstep with BTC, amplified by the company's aggressive financial engineering.

Accumulate Bitcoin (BTC) at current levels near $80,000, as the upcoming Clarity Act is expected to trigger massive institutional inflows from insurance companies and pension funds. For amplified returns, MicroStrategy (MSTR) remains a high-conviction leveraged play that typically outperforms BTC by 1.5x during bullish trends. Investors should monitor MSTR for potential equity offerings, which the company uses to aggressively acquire more Bitcoin and increase shareholder value. Consider STRC as it nears the $100 milestone, particularly for its utility as a yield-bearing "centi-stablecoin" across major blockchain networks like Solana and Ethereum. Advanced investors can maximize income by utilizing Pendle Finance to yield farm STRC, where returns have recently reached as high as 16.47%.

The Clarity Act serves as a massive institutional catalyst, positioning Bitcoin (BTC) as the primary beneficiary of new capital inflows from pension funds and insurance companies. Investors should maintain core exposure to MicroStrategy (MSTR) as the premier high-beta proxy for Bitcoin within traditional brokerage accounts. To navigate potential bans on passive stablecoin interest, pivot toward "activity-based" yield models or lending protocols like Aave that may bypass new restrictions. Strike Real Estate (STRC) offers a high-conviction opportunity to capture an 11.5% yield within traditional finance rails, especially as a compliant alternative to restricted stablecoins. Monitor the potential tokenization of STRC on decentralized exchanges like Hyperliquid, which could significantly increase liquidity and accessibility for on-chain investors.

Investors should closely monitor MicroStrategy (MSTR) during its Q1 earnings report on May 5th for updates on its cash reserves and "At-The-Market" equity program. Be cautious of the current MSTR price premium, as the stock is outperforming Bitcoin (BTC) by 4x, significantly higher than its historical 1.5x volatility ratio. With Bitcoin showing strength near $79,000, the "Fear and Greed Index" at 45 suggests the market is not yet overheated and has room for further growth. Monitor the performance of Nvidia (NVDA) and the Nasdaq, as Bitcoin remains highly correlated with high-growth tech stocks and broader software sector trends. Finally, track the legislative progress of the Clarity Act, which serves as a primary regulatory catalyst for institutional adoption and sustained price appreciation.

Zeta Global (ZETA) presents a high-conviction opportunity as an undervalued "Palantir of Marketing" that is currently mispriced alongside struggling legacy software firms like Salesforce (CRM). The company is growing revenue at 50% and free cash flow at 75%, yet it trades at a significant valuation discount compared to peers like The Trade Desk (TTD). Investors should focus on ZETA's proprietary "Identity Graph" and its new Athena AI agent, which provide a massive data moat and the ability to automate entire marketing departments. Management has signaled strong confidence through a $138 million share buyback program and conservative long-term guidance targeting $2.3 billion in revenue by 2028. This is a prime "operating leverage" play for those looking to invest in Agentic AI companies that own their data and can scale profits significantly faster than expenses.

Investors should avoid Spirit Airlines (SAVE) as the company effectively shuts down operations, signaling a total loss for shareholders. With the low-cost carrier market shrinking, look to buy the "Big Three"—Delta (DAL), United (UAL), and American (AAL)—which are positioned to increase margins through higher ticket prices and dominant loyalty programs. Exercise extreme caution with JetBlue (JBLU), as it faces high strategic risk and lacks the scale to compete with legacy carriers following its failed merger. For long-term diversification, Bitcoin (BTC) remains a high-conviction hedge against the "randomness" of government intervention and corporate bailouts. Monitor remaining low-cost players like Frontier (ULCC) and Allegiant (ALGT), but expect domestic travel costs to rise across the board as competition vanishes.

Investors should consider MicroStrategy (MSTR) as a high-beta play on Bitcoin (BTC), as the company continues to use its stock premium to aggressively acquire more cryptocurrency. For income-focused investors, STRC offers a potential 11.5% return, with a strategic "carry trade" opportunity available by borrowing at sub-5% rates through low-cost brokers like Robinhood or Interactive Brokers. Monitor NVIDIA (NVDA) earnings closely, as a positive report is expected to be the primary catalyst for a broader summer rally in growth and tech stocks. Be prepared for market volatility driven by new EU auto tariffs and a "hawkish" Federal Reserve, which suggests interest rates will remain higher for longer than initially anticipated. Shareholders in MSTR and STRC should check their brokerage accounts immediately to vote on critical proposals regarding share structures and distribution frequencies.

Investors should treat MicroStrategy (MSTR) as a high-beta, leveraged play on Bitcoin (BTC), particularly during windows when the company pauses its At-The-Market (ATM) equity offerings. While Bitcoin remains the premier long-term "movable asset" for wealth preservation, MSTR offers a more aggressive vehicle for those betting on a "risk-on" market environment. Within Big Tech, the recent sell-offs in NVIDIA (NVDA) and Meta (META) are viewed as overreactions, presenting buying opportunities in companies that own dominant distribution "pipes." Long-term investors should pivot away from human-capital-heavy industries and toward Land in prime locations like Manhattan or Miami, as AI and robotics are expected to demonetize labor and construction costs. For those seeking tax-efficient hard assets, Agricultural Land and Forests remain high-conviction alternatives to traditional real estate structures.

Meta (META) is currently the most compelling "Buy" in Big Tech, offering a superior valuation and a 9% recent dip that serves as an attractive entry point for its dominant AI-driven advertising business. While NVIDIA (NVDA) has surged, it remains a core holding with massive revenue visibility; investors should look toward its upcoming earnings report in late May as a major catalyst. Amazon (AMZN) is a preferred alternative to Google, providing better long-term value and unique AI upside through its significant stake in Anthropic. Conversely, Google (GOOGL) and Microsoft (MSFT) appear overextended at current valuations, with Microsoft facing specific long-term risks from AI-generated software disruption. For a high-upside speculative play, Zoom (ZM) is considered undervalued due to its indirect exposure to the massive valuation potential of Anthropic.